Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer

This study has been terminated.
(The sponsor decide to terminate)
Sponsor:
Information provided by (Responsible Party):
Biotech Pharmaceutical Co., Ltd.
ClinicalTrials.gov Identifier:
NCT00983047
First received: September 21, 2009
Last updated: August 25, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2015
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)